BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31052333)

  • 1. Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery.
    Rega-Kaun G; Ritzel D; Kaun C; Ebenbauer B; Thaler B; Prager M; Demyanets S; Wojta J; Hohensinner PJ
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric Surgery Is Accompanied by Changes in Extracellular Vesicle-Associated and Plasma Fatty Acid Binding Protein 4.
    Witczak JK; Min T; Prior SL; Stephens JW; James PE; Rees A
    Obes Surg; 2018 Mar; 28(3):767-774. PubMed ID: 28823103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated fasting and postprandial C-terminal telopeptide after Roux-en-Y gastric bypass.
    Maghsoodi N; Alaghband-Zadeh J; Cross GF; Werling M; Fändriks L; Docherty NG; Olbers T; Dew T; Sherwood RA; Vincent RP; le Roux CW
    Ann Clin Biochem; 2017 Jul; 54(4):495-500. PubMed ID: 27555664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Roux-en-Y Gastric Bypass on the Hepatocellular Function and Bile Flow of Obese Patients Assessed by Scintigraphy with DISIDA.
    Salgado Júnior W; Donadelli CA; Dos Santos JS; Nonino CB
    Obes Surg; 2016 Nov; 26(11):2718-2723. PubMed ID: 27094876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.
    Olbers T; Beamish AJ; Gronowitz E; Flodmark CE; Dahlgren J; Bruze G; Ekbom K; Friberg P; Göthberg G; Järvholm K; Karlsson J; Mårild S; Neovius M; Peltonen M; Marcus C
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):174-183. PubMed ID: 28065734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism.
    Goday Arno A; Farré M; Rodríguez-Morató J; Ramon JM; Pérez-Mañá C; Papaseit E; Civit E; Langohr K; Lí Carbó M; Boix DB; Nino OC; Le Roux JAF; Pera M; Grande L; de la Torre R
    Obes Surg; 2017 Dec; 27(12):3194-3201. PubMed ID: 28560524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of the nutritional status of vitamin A and the regression of hepatic steatosis after Roux-en-Y gastric bypass surgery for treatment of class III obesity.
    Oliveira e Silva LG; Manso JE; Silva RA; Pereira SE; Saboya Sobrinho CJ; Rangel CW
    Arq Bras Cir Dig; 2012; 25(4):250-6. PubMed ID: 23411924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-loop gastric bypass is more effective for weight loss but negatively impacts liver enzymes: a registry-based comprehensive first-year analysis.
    Spivak H; Munz Y; Rubin M; Raz I; Shohat T; Blumenfeld O
    Surg Obes Relat Dis; 2018 Feb; 14(2):175-180. PubMed ID: 29217131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine and amphetamine regulated transcript and brain-derived neurotrophic factor in morbid obesity. One-year follow-up after gastric bypass.
    Muñoz-Rodríguez JR; Agarrado A; Martín-Fernández J; Salas E; González-Martín C; Alguacil LF
    Surg Obes Relat Dis; 2018 Nov; 14(11):1732-1739. PubMed ID: 30274741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrient Transporter Expression in the Jejunum in Relation to Body Mass Index in Patients Undergoing Bariatric Surgery.
    Irving BA; Wood GC; Bennotti PN; Babu E; Deshpande A; Lent MR; Petrick A; Gabrielsen J; Strodel W; Gerhard GS; Still CD; Ganapathy V; Rolston DD
    Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery.
    Pardina E; Ferrer R; Rossell J; Ricart-Jané D; Méndez-Lara KA; Baena-Fustegueras JA; Lecube A; Julve J; Peinado-Onsurbe J
    Int J Obes (Lond); 2017 Sep; 41(9):1388-1393. PubMed ID: 28555086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery.
    Swarbrick MM; Austrheim-Smith IT; Stanhope KL; Van Loan MD; Ali MR; Wolfe BM; Havel PJ
    Diabetologia; 2006 Nov; 49(11):2552-8. PubMed ID: 17019599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric surgery in morbidly obese patients improves the atherogenic qualitative properties of the plasma lipoproteins.
    Julve J; Pardina E; Pérez-Cuéllar M; Ferrer R; Rossell J; Baena-Fustegueras JA; Fort JM; Lecube A; Blanco-Vaca F; Sánchez-Quesada JL; Peinado-Onsurbe J
    Atherosclerosis; 2014 May; 234(1):200-5. PubMed ID: 24674904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass.
    Gastaldelli A; Iaconelli A; Gaggini M; Magnone MC; Veneziani A; Rubino F; Mingrone G
    Diabetes Care; 2016 Nov; 39(11):1925-1931. PubMed ID: 27573937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of 3 bariatric surgery procedures: Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, and sleeve gastrectomy.
    Lee JH; Nguyen QN; Le QA
    Surg Obes Relat Dis; 2016 Jun; 12(5):997-1002. PubMed ID: 27220823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?
    Goday A; Benaiges D; Parri A; Ramón JM; Flores-Le Roux JA; Pedro Botet J;
    Surg Obes Relat Dis; 2014; 10(5):871-6. PubMed ID: 25282193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.
    Abbas M; Cumella L; Zhang Y; Choi J; Vemulapalli P; Melvin WS; Camacho D
    Obes Surg; 2015 Dec; 25(12):2251-6. PubMed ID: 26001882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding.
    Folini L; Veronelli A; Benetti A; Pozzato C; Cappelletti M; Masci E; Micheletto G; Pontiroli AE
    Acta Diabetol; 2014; 51(3):361-8. PubMed ID: 24085682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.